Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit

Liver Transplantation

Volumn 16, Issue 3, 2010, Pages 402-410

  Van Den Broek, Maartje A J ^a   Olde Damink, Steven W M ^a,b   Winkens, Bjorn ^c   Broelsch, Christoph E ^d   Malagó, Massimo ^b,d   Paul, Andreas ^d   Saner, Fuat H ^d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ABDOMINAL INFECTION; ACCURACY; ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; BODY MASS; COLD ISCHEMIA; FEMALE; GRAFT RECIPIENT; HUMAN; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG INFECTION; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX RATIO; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COHORT STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77749320144     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21987     Document Type: Article

References (37)

1. Saner FH, Olde Damink SW, Pavlakovic G, van den Broek MA, Rath PM, Sotiropoulos GC, et al. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation 2008;85:1564-1568.
2. Pfitzmann R, Nussler NC, Hippler-Benscheidt M, Neuhaus R, Neuhaus P. Long-term results after liver transplantation. Transpl Int 2008;21:234-246.
3. Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation - part I. Liver Transpl 2005;11:1452-1459.
4. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
5. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
6. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341: 515-518.
7. Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A, Beger HG. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 2000;26(suppl 2):S159-S164.
8. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34: 1996-2003.
9. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-217.
10. Bundesärztekammer. Bekanntmachungen: Richtlinien zur Organtransplantation gemäβ § 16 TPG. Dtsch Arztebl 2006;103:A3282-A3290.
11. Valentin-Gamazo C, Malago M, Karliova M, Lutz JT, Frilling A, Nadalin S, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl 2004;10:1087-1096.
12. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
13. Saner FH, Sotiropoulos GC, Radtke A, Fouzas I, Molmenti EP, Nadalin S, et al. Intensive care unit management of liver transplant patients: a formidable challenge for the intensivist. Transplant Proc 2008;40:3206-3208.
14. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25: 658-663.
15. Altman DG. Practical Statistics for Medical Research. 1st ed. London, United Kingdom: Chapman and Hall; 1991.
16. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982;247: 2543-2546.
17. Fazakas J, Gondos T, Varga M, Sarvary E, Horovitz P, Perner F. Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int 2003;16:465-470.
18. Prieto B, Llorente E, Gonzalez-Pinto I, Alvarez FV. Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and noninfectious postoperative complications. Clin Chem Lab Med 2008;46:660-666.
19. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998;24:680-684.
20. Kuse ER, Langefeld I, Jaeger K, Kulpmann WR. Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med 2000;28:555-559.
21. Eyraud D, Ben Ayed S, Tanguy ML, Vezinet C, Siksik JM, Bernard M, et al. Procalcitonin in liver transplantation: are high levels due to donors or recipients? Crit Care 2008;12:R85.
22. Meisner M, Muller V, Khakpour Z, Toegel E, Redl H. Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock 2003;19:187-190.
23. Kretzschmar M, Kruger A, Schirrmeister W. Procalcitonin following elective partial liver resection - origin from the liver? Acta Anaesthesiol Scand 2001;45:1162-1167.
24. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458-461.
25. Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, et al. Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann Surg 2007;245:315-325.
26. Piselli P, Zanfi C, Corazza V, Ferretti S, Scuderi M, Secchia SB, et al. Incidence and timing of infections after liver transplant in Italy. Transplant Proc 2007;39:1950-1952.
27. Garbino J, Romand JA, Pittet D, Giostra E, Mentha G, Suter P. Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience. Swiss Med Wkly 2005;135:587-593.
28. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005;241:905-916.
29. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and c-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217.
30. Kunz D, Pross M, Konig W, Lippert H, Manger T. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc 1998;30:2398-2399.
31. Cooper D, Sharples L, Cornelissen J, Wallwork J, Alexander G, Trull A. Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation. Transplant Proc 2001;33: 1808-1810.
32. Zazula R, Prucha M, Tyll T, Kieslichova E. Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin. Crit Care 2007;11:R131.
33. Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008;36:1147-1154.
34. Yokoyama Y, Schwacha MG, Samy TS, Bland KI, Chaudry IH. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res 2002;26:63-76.
35. Jalan R. Acute liver failure: current management and future prospects. J Hepatol 2005;42(suppl):S115-S123.
36. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-G26.
37. Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW, et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129:408-414.